TTRX Turn Therapeutics Inc

$TTRX Resharing again. I compared Turn’s results to Apogee’s, which came out a week apart from one another. Apogee raised $1.2B on those results and are in the acquisition process now, for $10.9B. Turn has gone from the $170M market cap to over $400M today. It’s still undervalued and I suspect the next phase 2 results later this year will catapult it to new heights.